Abstract | BACKGROUND: OBJECTIVES: To evaluate the safety and the topical efficacy of CB-03-01 1% cream in acne vulgaris as compared with placebo and with tretinoin 0·05% cream (Retin-A® ; Janssen-Cilag). METHODS: Seventy-seven men with facial acne scored 2-3 according to Investigator's Global Assessment ( IGA) were randomized to receive placebo cream (n = 15), or CB-03-01 1% cream ( n = 30), or tretinoin 0·05% cream (n = 32) once a day at bedtime for 8 weeks. Clinical efficacy was evaluated every 2 weeks including total lesion count (TLC), inflammatory lesion count (ILC), acne severity index (ASI) and IGA. Safety assessment included local irritancy score, laboratory tests, physical examination, vital signs and recording of adverse events. RESULTS:
CB-03-01 1% cream was very well tolerated, and was significantly better than placebo regarding TLC (P = 0·0017), ILC (P = 0·0134) and ASI (P = 0·0090), and also clinically more effective than comparator. The product also induced a faster attainment of 50% improvement in all the above parameters. CONCLUSIONS:
|
Authors | V Trifu, G-S Tiplica, E Naumescu, L Zalupca, L Moro, G Celasco |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 165
Issue 1
Pg. 177-83
(Jul 2011)
ISSN: 1365-2133 [Electronic] England |
PMID | 21428978
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011. |
Chemical References |
- Androgen Antagonists
- Anti-Inflammatory Agents
- Emollients
- Keratolytic Agents
- Propionates
- Tretinoin
- Cortodoxone
- Clascoterone
|
Topics |
- Acne Vulgaris
(drug therapy, pathology)
- Administration, Topical
- Adolescent
- Adult
- Androgen Antagonists
(therapeutic use)
- Anti-Inflammatory Agents
(therapeutic use)
- Cortodoxone
(analogs & derivatives, therapeutic use)
- Double-Blind Method
- Emollients
(therapeutic use)
- Humans
- Keratolytic Agents
(therapeutic use)
- Male
- Middle Aged
- Pilot Projects
- Propionates
(therapeutic use)
- Severity of Illness Index
- Tretinoin
(therapeutic use)
- Young Adult
|